Skip to main content
GANX logo

GANX · Gain Therapeutics, Inc. · Held by Funds

Track GANX — free
$1.26 -0.03 (-2.33%) At close · Oct 23
Market Cap
$54.99M
Shares
43.64M
Volume · Oct 23 645.03K Avg daily vol (3M) 503.57K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of GANX by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 2.13% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.81% 353,921
Index ETFs 1.32% 577,109
Active ETFs 0.00% 0
Active funds 0.09% 39,734
Unclassified 0.00% 0
All registered funds 2.22% 970,764
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding GANX

10 fund positions
Fund Balance Value % of Fund Open
Showing 1–10 of 10 positions
Key facts CIK 1819411 CUSIP 36269B105 13F (30d) 5 filings 5 filers Visit website Investor relations